Serial 99293055
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99293055
- Registration number
- 8184498
- Mark type
- Design / logo
- Filed
- 20 Jul 2025
- Published for opposition
- 03 Feb 2026
- Registered
- 24 Mar 2026
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; cultures of microorganisms for medical or veterinary use; medicated sweets; dietetic preparations adapted for medical purposes; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
Owner
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Sept 2025 — NON-FINAL ACTION E-MAILED
- 10 Sept 2025 — NON-FINAL ACTION WRITTEN
- 28 Aug 2025 — ASSIGNED TO EXAMINER
- 13 Aug 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 13 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED